Concepedia

Genetically based N-acetyltransferase metabolic polymorphism and low-level environmental exposure to carcinogens

Paolo Vineis, Helmut Bartsch, Neil E. Caporaso, Anita M. Harrington, Fred F. Kadlubar, Maria Teresa Landi, C. Malaveille, Peter G. Shields, Paul L. Skipper, Glenn Talaska,

Nature · 1994 · 275 citations · 11 references

DOI

Concepts

References

11

IARC Monographs on the Evaluation of Carcinogenic Risks to Humans

A. J. Zuckerman · Journal of Clinical Pathology · 1995 · 8.8K citations · Full text

, , +14

Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites

Marguerite A. Butler, Nicholas P. Lang, J.F. Young et al. · Pharmacogenetics · 1992 · 418 citations

, , +17

Molecular mechanism of slow acetylation of drugs and carcinogens in humans.

Martin Blum, A Demierre, Denis M. Grant et al. · Proceedings of the National Academy of Sciences · 1991 · 347 citations

, , +14

SHORT COMMUNICATION: Genotype/phenotype discordance for human arylamine <i>N</i>-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African-Americans

Douglas A. Bell, Jack A. Taylor, Marguerite A. Butler et al. · Carcinogenesis · 1993 · 292 citations

, , +11

Smoking related carcinogen-DNA adducts in biopsy samples of human urinary bladder: identification of N-(deoxyguanosin-8-yl)-4-aminobiphenyl as a major adduct.

Glenn Talaska, A Z al-Juburi, Fred F. Kadlubar · Proceedings of the National Academy of Sciences · 1991 · 213 citations

, , +13